Novartis publishes long-term data from SMA gene therapy

Novartis has produced data demonstrating its Zolgensma gene therapy produces long term benefits in the rare muscle wasting disease spinal muscular atrophy – information that will be closely

Oxford University prepares for coronavirus vaccine trial

Scientists from the University of Oxford say they have identified a potential vaccine for the SARS-CoV-2 coronavirus that is the cause of the COVID-19 epidemic, which has claimed more than

Gilead halts 'compassionate use' of potential coronavirus dr...

Gilead has said it has stopped accepting “compassionate use” requests for its potential coronavirus antiviral remdesivir because it cannot keep pace with demand as health systems become ove

Lilly, Galapagos suspend trials as COVID-19 hits health syst...

AbbVie’s Kaletra doesn’t work in COVID-19, say Chinese scien...

Lilly's CEO warns against medicine hoarding during coronavir...

Eli Lilly’s CEO has warned against the hoarding of medicines by individual states and countries in the coronavirus crisis, saying that it will hamper the effort to fight the virus.